- Home
- ETON vs NWPX Comparison
ETON vs NWPX Comparison
Compare ETON & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- NWPX
- Stock Information
- Founded
- ETON 2017
- NWPX 1966
- Country
- ETON United States
- NWPX United States
- Employees
- ETON N/A
- NWPX N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- NWPX Steel/Iron Ore
- Sector
- ETON Health Care
- NWPX Industrials
- Exchange
- ETON Nasdaq
- NWPX Nasdaq
- Market Cap
- ETON 388.3M
- NWPX 420.8M
- IPO Year
- ETON 2018
- NWPX 1995
- Fundamental
- Price
- ETON $17.31
- NWPX $52.96
- Analyst Decision
- ETON Strong Buy
- NWPX Hold
- Analyst Count
- ETON 3
- NWPX 1
- Target Price
- ETON $29.67
- NWPX $55.00
- AVG Volume (30 Days)
- ETON 329.2K
- NWPX 67.1K
- Earning Date
- ETON 08-07-2025
- NWPX 08-07-2025
- Dividend Yield
- ETON N/A
- NWPX N/A
- EPS Growth
- ETON N/A
- NWPX 32.83
- EPS
- ETON N/A
- NWPX 3.32
- Revenue
- ETON $58,181,000.00
- NWPX $499,125,000.00
- Revenue This Year
- ETON $105.25
- NWPX $4.00
- Revenue Next Year
- ETON $40.84
- NWPX $3.96
- P/E Ratio
- ETON N/A
- NWPX $15.95
- Revenue Growth
- ETON 85.40
- NWPX 5.83
- 52 Week Low
- ETON $4.47
- NWPX $36.97
- 52 Week High
- ETON $21.48
- NWPX $57.76
- Technical
- Relative Strength Index (RSI)
- ETON 61.58
- NWPX 68.05
- Support Level
- ETON $17.02
- NWPX $50.21
- Resistance Level
- ETON $17.77
- NWPX $53.28
- Average True Range (ATR)
- ETON 0.69
- NWPX 1.40
- MACD
- ETON 0.03
- NWPX 0.05
- Stochastic Oscillator
- ETON 78.80
- NWPX 69.48
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NWPX Northwest Pipe Company
NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.